Rare diseases
Investigational molecules
Locations
Back to Italy475 clinical trials in Parma, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity
ItalyPhase III Randomized Study of Balcinrenone and Dapagliflozin Versus Dapagliflozin on Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease Stage 3b‑4
ItalyPhase 2 Study of Nemolizumab for Skin Thickening in Adults with Systemic Sclerosis
ItalyPhase 3 study of ZL-1310 versus topotecan hydrochloride in patients with relapsed small cell lung cancer
ItalyStudy of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
ItalyStudy of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing
ItalyStudy of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it
ItalyStudy on IPN10200 for Treating Cervical Dystonia in Adults
ItalyStudy on the Safety and Effectiveness of BNT327 with Chemotherapy for Patients with Non-Small Cell Lung Cancer
ItalyStudy on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections
ItalyStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
ItalyStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
ItalyThe busiest research cities in the country
What the registry says about research in the country
Groundbreaking studies focusing on multiple myeloma, lung cancer, and breast cancer treatments. Investigations include innovative immunotherapy approaches and targeted therapies for various cancer types.
Research emphasizes personalized treatment approaches and combination therapies to improve patient outcomes.
Studies examining treatments for respiratory syncytial virus (RSV) infections in high-risk populations. Advanced research into preventive therapies and management strategies.
Focus on developing protective measures for vulnerable patient populations.
Clinical trials evaluating new approaches to kidney transplantation and prevention of complications. Research on reducing delayed graft function and improving transplant outcomes.
Emphasis on enhancing long-term transplant success rates.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
